Faculty, Staff and Student Publications

 

Open-access journal articles from UTHealth GSBS faculty, staff and students.

Follow


Submissions from 2025

PDF

Clinical Validity of FoundationOne Liquid CDx for Detection of BRAF V600E in Colorectal Cancer, Rona Yaeger, Jean-François Martini, Lincoln Pasquina, et al.

PDF

Spontaneous Cervical and Mediastinal Hematoma Due to Rupture of Inferior Thyroid Artery, Takayuki Yamada, Satoru Yanagaki, Nozomi Satani, et al.

PDF

Diverse Roles of Antibodies in Antibody-Drug Conjugates, Aiko Yamaguchi and H Charles Manning

PDF

TREM2 Depletion in Pancreatic Cancer Elicits Pathogenic Inflammation and Accelerates Tumor Progression via Enriching IL-1β+ Macrophages, Daowei Yang, Xinlei Sun, Hua Wang, et al.

PDF

Blunted CD40-Responsive Enhancer Activation in CREBBP-Mutant Lymphomas Can Be Restored by Enforced CD4 T-Cell Engagement, Haopeng Yang, Wenchao Zhang, Vida Ravanmehr, et al.

PDF

Mature and Migratory Dendritic Cells Promote Immune Infiltration and Response to Anti-Pd-1 Checkpoint Blockade in Metastatic Melanoma, Jiekun Yang, Cassia Wang, Doris Fu, et al.

PDF

Alleviation of Liver Fibrosis by Inhibiting a Non-canonical ATF4-Regulated Enhancer Program in Hepatic Stellate Cells, Li-Xian Yang, Chuangye Qi, Si Lu, et al.

PDF

First-in-Human Phase 1 Study of KHK2455 Monotherapy and in Combination With Mogamulizumab in Patients With Advanced Solid Tumors, Timothy A Yap, Olivier Rixe, Capucine Baldini, et al.

PDF

Therapy, Safety, and Logistics of Preoperative vs Postoperative Stereotactic Radiation Therapy: A Preliminary Analysis of a Randomized Clinical Trial, Debra Nana Yeboa, Jing Li, Ruitao Lin, et al.

PDF

Genetics and Biology of Pancreatic Ductal Adenocarcinoma, Haoqiang Ying, Alec C Kimmelman, Nabeel Bardeesy, et al.

PDF

Metabolic Reprogramming Driven by Ant2 Deficiency Augments T Cell Function and Anti-Tumor Immunity in Mice, Omri Yosef, Leonor Cohen-Daniel, Oded Shamriz, et al.

PDF

Fecal Immunochemical Test Positivity Thresholds: An International Survey of Population-Based Screening Programs, Graeme P Young, Sally C Benton, Robert S Bresalier, et al.

PDF

A Brief History of Circadian Time in the Heart, Martin E Young, Vanya Khanna, Mallory Metcalfe, et al.

PDF

Clinical and Molecular Characteristics of Patients With Brain Metastasis Secondary to Pancreatic Ductal Adenocarcinoma, Mahmoud Yousef, Mark W Hurd, Abdelrahman Yousef, et al.

PDF

KRAS Mutation Detection by Liquid Biopsy for Pancreatic Ductal Adenocarcinoma, Mahmoud Yousef, Abdelrahman Yousef, Mark W Hurd, et al.

PDF

Diroximel Fumarate Acts Through Nrf2 to Attenuate Methylglyoxal-Induced Nociception in Mice and Decrease ISR Activation in DRG Neurons, Muhammad Saad Yousuf, Marisol Mancilla Moreno, Brodie J Woodall, et al.

PDF

Uncertainty-Guided Pancreatic Tumor Auto-Segmentation With Tversky Ensemble, Cenji Yu, Skylar S Gay, Aashish C Gupta, et al.

PDF

Association of SIRT6 Expression With Risk of Pneumonitis Induced by Radiotherapy in Cancer Patients, Fengyuan Yu, Zheng Gong, Yuan Li, et al.

PDF

Psychometric Evaluation of the Scleroderma Skin Questionnaire: A Novel Patient-Reported Outcome for Skin Disease in Patients With Systemic Sclerosis, Jeong Min Yu, John M VanBuren, Angela Child, et al.

PDF

Investigative Needle Core Biopsies Support Multimodal Deep-Data Generation in Glioblastoma, Kenny K H Yu, Sreyashi Basu, Gerard Baquer, et al.

PDF

Differential Efficacy of Bevacizumab and Erlotinib in Preclinical Models of Renal Medullary Carcinoma and Fumarate Hydratase-Deficient Renal Cell Carcinoma, Niki M Zacharias, Manuel Ozambela, Menuka Karki, et al.

PDF

Global and Regional Disparities in Access to Specialist Sarcoma Services, Tomas Zamora, Eduardo Botello, Thomas Jenkins, et al.

PDF

Characterization and Clinical Implications of p53 Dysfunction in Patients With Myelodysplastic Syndromes, Matteo Zampini, Elena Riva, Luca Lanino, et al.

PDF

Deep Dive into Targeted Therapies: Understanding IDH1-Mutant AML Treatments [Podcast], Amer M Zeidan and Courtney DiNardo

PDF

Loncastuximab in High-Risk and Heavily Pretreated Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Realworld Analysis From 21 Us Centers, Viktoriya Zelikson, Ashwath Gurumurthi, Yazeed Sawalha, et al.